Moderna Vaccine Trial Shows More Than 94% Effectiveness

On the heels of Pfizer’s announcement of a successful vaccine trial, Moderna released data showing an even more effective vaccine. How do they differ and what are both sides’ reaction to the positive news?


Following up on reports last week that Moderna was expected to release covid-19 vaccine trial data, the pharmaceutical company on Monday unveiled its testing that shows the coronavirus shots to be nearly 95% effective.


reporting from the left side of the aisle


  • The New York Times reporting played down enthusiasm with the Moderna announcement, saying it produced a “modicum of excitement” among public health experts and quoted the head of the World Health Organization, “A vaccine on its own will not end the pandemic.”
  • Vox focused on managing expectations, saying the road between vaccine trials and global distribution of an approved vaccine is “fraught with logistical challenges.”
  • CNN echoed similar warnings, saying promising news on a vaccine does not diminish the “dangerous stretch” of coronavirus cases the United States is currently experiencing.



  • The Wall Street Journal detailed the potentially negative stock implications for pharmaceutical companies working on covid-19 vaccines.
  • Quoting former Commissioner of the Food and Drug Administration Scott Gottlieb, National Review’s Jim Geraghty optimistically declared “we’re almost out of this ordeal” after the news from Moderna.
  • The head of the United States’ Operation Warp Speed project hailed it as a massive success on Fox News Channel, saying after Pfizer and Moderna, several other vaccine candidates are expected to follow suit.
  • Fox News also reported on President Trump’s praise of Moderna’s vaccine and took some credit for its quick process through Operation Warp Speed.

Return to Freespoke

© Dallas Gerber, 2020